Miro Benes
Earnings Unscripted: Stock Earnings Calls & Analysis
Earnings Unscripted delivers short-form earnings call analysis. Each episode breaks down corporate earnings calls, compares management commentary with financial results, and highlights key insights for investors seeking fast earnings analysis.
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
Nokia (NOK): Ramping California laser fabs to feed an 18-month AI bottleneck [Q1 2026] 23.04.2026 11:36
Nokia's Q1 2026 isn't just a traditional telecom print; it reveals an aggressive restructuring to become the plumbing of the AI supercycle. In ~10 minutes: - Why legacy fixed network revenue was deliberately shrunk by 13%. - A 49% YoY surge in newly focused AI and cloud sales. - Surging 18-month lead times in the optical gear supply chain. - How the recent Infinera acquisition bypassed the...
Union Pacific (UNP): The $1T Berkshire excuse & AI-automated yards [Q1 2026] 23.04.2026 11:15
Union Pacific is freezing its stock buybacks to bankroll a historic rail monopoly in Q1 2026, relying on hyper-efficient AI yard technology to offset slumping freight volumes. In ~10 minutes: • Why shares surged 7% despite a 1% drop in total volume. • Predicting human rail yard errors 2 hours before they happen. • CEO Jim Vena's $1T Berkshire Hathaway antitrust defense. 🚂 • The $4/gallon fuel...
Lockheed Martin (LMT): The $291M software glitch & rewriting defense rules [Q1 2026] 23.04.2026 9:21
Lockheed Martin’s Q1 2026 earnings revealed a sharp paradox: unmatched battlefield superiority overshadowed by a cash-draining back-office billing failure. In ~10 minutes: • Why a painful ERP software transition choked $291M in free cash flow • The abrupt $0 halt to quarterly share repurchases to conserve capital • Forcing the Pentagon to guarantee capital investments with "clawback" claus...
ServiceNow (NOW): AI token pricing, a $4B cyber loan & the DOJ probe [Q1 2026] 23.04.2026 12:02
ServiceNow's Q1 2026 print delivered an impressive revenue beat, but the market punished the stock over a softer backlog and a rapid shift away from traditional software pricing. In ~10 minutes: • Why 50% of net-new business is now non-seat-based. 🤖 • Taking on a $4B term loan for the Armis buyout. • How Middle East sovereign cloud deals hit Q1 revenue recognition. • A buried DOJ probe regard...
Kinder Morgan (KMI): The AI power boom & squeezing yield from empty tanks [Q1 2026] 23.04.2026 8:47
While Big Tech fixates on building smarter AI models, Kinder Morgan's Q1 2026 results prove the real money is in piping the natural gas to keep those data centers running. In ~10 minutes: • How Winter Storm Fern drove a 36% net income surge. • Getting paid to empty tanks, then re-leasing at higher rates. • Killing crude pipelines to capture the natural gas liquid boom. • Why a March Treasury t...
Boeing (BA): Missing luxury seats, 777X teardowns & a $6.9B debt flush [Q1 2026] 23.04.2026 10:52
Despite burning nearly 30% of its cash reserves to shred $6.9 billion in debt, Boeing's (BA) Q1 2026 earnings revealed an aerospace giant finally regaining its operational footing. In ~10 minutes: - How uncertified luxury seats are paralyzing fully-built 787 deliveries. - The massive labor black hole of "unbuilding" thirty 777X test planes. - Why the defense segment finally stopped ble...
Lam Research (LRCX): The clean room squeeze & AI's $40B memory upgrade [Q3 2026] 23.04.2026 10:36
In Q3 2026, Lam Research proved the AI boom isn't just about processors anymore—it’s triggering a massive memory equipment supercycle constrained entirely by a lack of physical clean room real estate. In ~10 minutes: - Why global chip equipment growth is waiting on concrete to dry. - How "Dextro" collaborative robots are expanding margins in the dark. - The desperate client that halted...
Tesla (TSLA): The $25B AI spending spree & the Hardware 3 reality check [Q1 2026] 23.04.2026 11:51
Tesla's (TSLA) Q1 2026 earnings revealed a struggling auto business funding a massively expensive, $25 billion pivot to custom AI and robotics. In ~10 minutes: • Why auto margins slumped while energy hit a deceptive 39.5%. • The painful reality that Hardware 3 lacks unsupervised FSD bandwidth. • Elon's bold $3 billion push to build a semiconductor "Terafab." 🤖 • Why an overly caut...
United Airlines (UAL): The $340M fuel shock & the unbundling of business class [Q1 2026] 22.04.2026 9:02
United Airlines delivered record Q1 2026 revenue, but a massive jet fuel spike forced management to slash capacity and aggressively unbundle premium cabins. ✈️ In this episode: • How a $340M fuel headwind drove an 8% stock drop. • Slashing 5% of planned capacity to protect profit margins. • Why "Basic Economy" rules are coming to business class. • Retiring $3.1B in debt to chase investment...
Alaska Air (ALK): The 400% Singapore fuel trap & masking the Hawaiian numbers [Q1 2026] 22.04.2026 12:45
Alaska Air's Q1 was hijacked by an unprecedented Pacific fuel shock and freak weather, forcing management to pull 2026 guidance while quietly blurring their accounting. In ~10 minutes: • How a 400% spike in Singapore refining crushed margins. • Why the sudden pause on their $203M stock buyback. • Management's quiet move to hide Hawaiian’s standalone financials. • The $1 billion BofA loyalt...
Halliburton (HAL): Sold-out shale fleets & the literal cost of global conflict [Q1 2026] 22.04.2026 10:57
Halliburton’s Q1 2026 report pairs sold-out North American fracking capacity with a rare, highly specific financial penalty for disruptions in the Middle East. In this episode: • Why the North American fracking calendar is completely sold out. • How geopolitical shipping chaos explicitly cost the company 3 cents per share. • Exporting elite "Zeus" electric fleets to Argentina’s Vaca Muerta...
UnitedHealth Group (UNH): Shedding 1.3M members & the 30-second AI doctor [Q1 2026] 22.04.2026 10:23
UnitedHealth Group delivered a massive earnings beat in Q1 2026 by deploying rapid AI automation and intentionally shrinking its own customer base. In ~10 minutes ⏱️: - Why UNH is deliberately dumping 1.3M Medicare Advantage members. - How AI cut prior authorization waits from 8 hours to 30 seconds. - The accounting maneuver hiding inside Q1's 83.9% medical care ratio. - Why 75% of the core in...
Northrop Grumman (NOC): Selling its own planes & the $2.5B bomber bill [Q1 2026] 22.04.2026 11:44
Northrop Grumman’s Q1 2026 proved defense demand is sky-high, but scaling B-21 bomber production will require billions in cash before it prints steady profit. In ~10 minutes: • Selling a company-owned test plane to the US Air Force • Why an unexpected space launch anomaly cost $71 million 🚀 • The massive $2.5B capex bill looming in 2027 and 2028 • Why the stock dumped 6.6% despite a 10% operating...
RTX Corporation (RTX): Reusable drone swarms & the 1% headcount scaling code [Q1 2026] 22.04.2026 11:37
RTX Corporation delivered massive double-digit top-line growth in Q1 2026 while barely expanding its workforce, yet the market inexplicably punished the stock. In ~10 minutes: • Why organic sales surged 10% on a microscopic 1% headcount increase. • How the Supreme Court triggered an unmodeled $500 million cash refund. • Five landmark DoD agreements radically shifting missile capacity funding. • Th...
GE Aerospace (GE): $23B in panic-buying & a broken supply chain [Q1 2026] 22.04.2026 10:07
GE Aerospace's Q1 2026 reveals a booming business where the absolute biggest crisis is literally having too many aircraft to service. In this episode: • Why airlines panic-buying jets drove an 87% order surge • The 70% backlog spike in delayed spare engine parts • Margin erosion caused by an influx of new engine deliveries • Why management capped full-year guidance over geopolitical conflict •...
Nano-X Imaging (NNOX): A $17M factory write-off & the med-tech waiting game [Q4 2025] 21.04.2026 13:29
Nano-X Imaging's Q4 2025 was a stark reality check, anchored by a massive $17.5 million impairment charge that highlights the painful gap between medical hardware ambition and actual commercial scale. In ~10 minutes: • Why management finally pulled the plug on their South Korean chip fab • How the Vaso Health IT acquisition bought instant software revenue • The bureaucratic bottlenecks pushing...
Cleveland-Cliffs (CLF): An $80M weather trap & the death of the aluminum car [Q1 2026] 21.04.2026 10:47
Cleveland-Cliffs bounced back in Q1 2026, dodging a massive weather-driven cost spike while quietly winning major automakers back from the aluminum EV dream. In ~10 minutes: • Why automakers are retreating from aluminum to use high-strength steel. • How an $80 million winter storm wrecked their un-hedged gas margins. • Why the Canadian spot market is trading at a bizarre 40% discount. • The absolu...
Ericsson (ERIC): The hidden AI tax & pivoting 5G to war-time tech [Q1 2026] 17.04.2026 12:34
Ericsson's Q1 2026 earnings reveal a harsh paradox: while management brilliantly defended a 47.2% gross margin through supply chain judo, they are being actively squeezed by the very AI supercycle enriching the rest of the tech sector. In ~10 minutes: • Why the surging AI chip market is a hidden tax on telecom hardware. • How 5G is pivoting to drone-detection and naval military contracts. • Th...
Alcoa Corporation (AA): Aluminum strength lifted profit, but cash flow went negative [Q1 2026] 17.04.2026 11:07
Alcoa’s Q1 FY2026 was a split-screen quarter: stronger aluminum pricing lifted profit, while alumina weakness and working-capital timing crushed cash flow. In this episode: - Aluminum EBITDA jumped as realized prices rose, costs held. - Alumina EBITDA turned negative on lower shipments and pricing. - Free cash flow fell to -$298M on timing-heavy working capital. - Inventory repositioning deferred...
Netflix (NFLX): The Warner fee, Japan's surge and a tougher Q2 read [Q1 2026] 17.04.2026 11:20
Netflix's Q1 FY2026 was a real operating improvement wrapped inside a one-time $2.8B Warner termination fee, which is why the numbers looked great and the stock still sold off. In this episode: - Revenue rose to $12.25B, but UCAN slipped sequentially - Operating margin hit 32.3% as costs and marketing fell - Roughly three quarters of pretax improvement came below the line - Japan led member gr...
Abbott Laboratories (ABT): Fixing a 9-month colonoscopy queue & rare deflation [Q1 2026] 16.04.2026 12:36
Abbott Laboratories posted decent Q1 2026 numbers, but a massive $21 billion cancer-testing acquisition has Wall Street spooked by immediate EPS dilution and muddy comparability metrics. In ~10 minutes: • Why 3-to-9 month colonoscopy wait times justify the Exact Sciences buyout. • Abbott’s rare corporate decision to cut adult nutrition prices to revive volume. • Supply chain war rooms buffering lo...
TSMC (TSM): The $56B agentic AI mandate & a permanent globalization tax [Q1 2026] 16.04.2026 9:56
In Q1 2026, TSMC's shift into manufacturing hardware for "Agentic AI" triggered a historic capital expenditure run rate, alongside stark warnings about the permanent structural costs of global expansion. In ~10 minutes: • High Performance Computing absorbs 61% of total wafer revenue. • Agentic AI forces capital expenditure guidance to a $56B limit. • CEO shuts down fast-track rumors: n...
ASML (ASML): 1,000-watt lasers, software patches & the €40B geopolitics shrug [Q1 2026] 15.04.2026 8:38
Despite a double-digit drop in system sales, ASML’s Q1 2026 gross margins surged to 53% as highly lucrative software upgrades rescued the quarter's profitability. In ~10 minutes: • How PEP software patches physically push EUV throughput to 230 WpH. • The massive €13B operating cash flow swing and working capital drag. • Firing lasers at supersonic tin to break the 1,000-watt light barrier. • W...
CarMax (KMX): The hotel CEO, algorithmic price chops & sub-prime risk [Q4 2026] 15.04.2026 11:11
CarMax essentially abandoned its long-held margin protections in Q4, intentionally slashing vehicle prices to revive stalled sales volume while quietly taking on riskier consumer debt. In ~10 minutes: • How the new CEO is applying hotel strategies to used cars • The algorithmic math behind their surgical $1,000 price drops • Why sub-prime auto loan penetration doubled in twelve months • The liquid...
Johnson & Johnson (JNJ): The Stelara cliff & obsoleting rivals on purpose [Q1 2026] 15.04.2026 10:36
Johnson & Johnson’s blockbuster drug Stelara just fell off a 62% cliff, but the healthcare giant's portfolio still managed to post double-digit operational growth in Q1 2026. In ~10 minutes: • Why GAAP net income dropped 52% on a phantom talc accounting reversal. • Defending Shockwave's cardiovascular monopoly with an aggressive Gen-5 product pivot. • How tariffs and massive front-load...
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.